[1]
“Reasons of treatment switching from first generation to second and third generations of TKIs among CML patients in Iraq -Kurdistan region from 2014-2024”, JOC, vol. 24, no. 8s, pp. 360–368, Oct. 2025, doi: 10.64149/J.Carcinog.24.8s.360-368.